U.S. Drug Sales Top $329 Billion In 2013, Up 3.2% – IMS Report
This article was originally published in The Pink Sheet Daily
Executive Summary
IMS Health’s report on U.S. drug spending in 2013 shows a return to growth last year after a decline in 2012, with a lower impact of brands losing patent protection being an important factor, as well as brand price increases.